Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials
- 1 October 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (10), 593-603
- https://doi.org/10.1016/s1470-2045(02)00873-2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Surgical Results for Hepatocellular Carcinoma with Macroscopic Portal Vein Tumor ThrombosisJournal of the American College of Surgeons, 2000
- Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring systemJournal of the American College of Surgeons, 2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinomaBritish Journal of Surgery, 1996
- Long interval between HCV infection and development of hepatocellular carcinomaLiver International, 1995
- Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisalBritish Journal of Surgery, 1995
- Multiple hepatocellular carcinomas at the early stage have different clonalityGastroenterology, 1993
- Postoperative chemoimmunotherapy for the treatment of liver cancerSeminars in Surgical Oncology, 1993
- The 11 -year pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991Journal of Surgical Oncology, 1993
- Multicentric Independent Development of Hepatocellular Carcinoma Revealed by Analysis of Hepatitis B Virus Integration PatternThe American Journal of Surgical Pathology, 1989